Pharma & Biotech

Legend Biotech Corp has reached a pivotal financial turning point. The company's cell therapy, CARVYKTI, became profitable in the last...

Talphera has achieved a significant enrollment milestone for its lead investigational drug, Niyad. The company announced that patient recruitment for...

The German pharmaceutical packaging specialist Gerresheimer finds itself in a severe predicament, facing a perfect storm of delayed financial reporting,...

The architects of Germany's celebrated vaccine breakthrough are stepping back from day-to-day leadership. BioNTech SE's co-founders, Uğur Şahin and Özlem...

Recent developments at Anixa Biosciences point to significant progress across its oncology pipeline. The company's latest annual shareholder meeting served...

Pharmaceutical giant Eli Lilly is making a substantial long-term commitment to China, targeting the nation as its next major growth...

The German pharmaceutical and agricultural giant Bayer finds itself at a critical juncture. Its immediate prospects hinge on two pivotal...

Bioage Labs is capturing significant attention from major investment banks. As the biotechnology firm advances its pipeline targeting age-related metabolic...

Investors in Merck are grappling with uncertainty following the U.S. market entry of generic competitors for Mavenclad, a key multiple...

In a notable display of conviction, two senior executives at the German pharmaceutical and life sciences giant Bayer AG recently...